Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.

Attention-Deficit/Hyperactivity Disorder (ADHD) Clinical Trial

Official title:
A Randomized, Multi-center, Double-blind, Placebo-controlled, Cross-over Study Evaluating the Safety and Efficacy of Dex-Methylphenidate Extended Release 30 mg vs. 20 mg as Measured by SKAMP-Combined Scores in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.

Status Completed

Clinical Trial Summary

This study will evaluate the efficacy and safety of Dex-Methylphenidate Extended Release 30 mg compared to 20 mg in pediatric patients ages 6-12 with Attention-Deficit Hyperactivity Disorder (ADHD) in a 12-hour laboratory classroom setting.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Attention Deficit Disorder with Hyperactivity
Attention-Deficit/Hyperactivity Disorder (ADHD)
Hyperkinesis

Clinical Trial Details

NCT number	NCT00776009
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 4
Start date	October 2008
Completion date	December 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02150668` - Efficacy of an Organizational Skills Intervention for Middle School Students With ADHD	N/A
Completed	`NCT00631280` - Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD	N/A
Recruiting	`NCT05809388` - Virtual Reality for Parent Training Intervention	N/A
Recruiting	`NCT00252278` - Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents	Phase 4
Completed	`NCT04016779` - Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD	Phase 3
Completed	`NCT00307268` - Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD	N/A
Completed	`NCT01107496` - Evaluation of Immediate-Release Viloxazine in Adults With ADHD	Phase 1/Phase 2
Completed	`NCT04786990` - Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD	Phase 4
Completed	`NCT00475735` - A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)	Phase 2
Completed	`NCT00711724` - Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD	N/A
Recruiting	`NCT06215144` - Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD	Phase 2/Phase 3
Completed	`NCT02633527` - Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD	Phase 2
Withdrawn	`NCT00323700` - A Naturalistic Prospective Study of Treatment Effectiveness for Attention-Deficit/Hyperactivity Disorder (ADHD)	N/A
Not yet recruiting	`NCT04532190` - Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder	N/A
Withdrawn	`NCT00931398` - Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate	Phase 4